PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
The goal of the PGY2 Investigational Drugs and Research residency is to provide candidates with the specialized knowledge and skills to operate as an effective and expert practitioner in research pharmacy. This will be accomplished through focused experiential rotations, a combination of didactic and hands-on learning, and an opportunity to further advanced the field through a research or quality improvement project. Residents will participate in the operational aspects of research pharmacy, including budget preparation, feasibility analysis, investigational product management and the clinical aspects of safe management of clinical trial patients. In addition, residents will have the opportunity to interact with world-renowned researchers in both oncology and non-oncology areas across the medical center. By the end of their PGY-2 program, the resident will have the training required to seek a specialized research pharmacist position in a variety of settings including hospitals, academia and industry.
Residents completing the PGY2 Investigational Drugs and Research Residency are eligible to receive a PGY2 Investigational Drugs and Research Certificate. This program will be in pre-candidate status and upon hiring of the first resident, will apply for ASHP accreditation.
Investigational drug service (IDS) operations and care of research patients are the backbone of this residency experience. The Ohio State University Wexner Medical Center has many opportunities to interact with leading researchers in diverse fields of medicine. Currently, the OSU IDS manages over 700 clinical trials, about 80% of which are in the oncology area. The James Cancer Hospital hosts a robust Phase 1 program averaging 70 to 80 active trials. After the core IDS rotation, residents will be assigned a portfolio of clinical trials to fully operationalize and manage from inception to end functioning as the de facto primary lead research pharmacist. In addition, the resident will attend Institutional Review Board Meetings on a regular basis and have the opportunity to collaborate with our innovative Drug Development Institute. Clinical rotations will be on services with a high research focus. Most services are teaching services and may be composed of an attending physician, fellow (depending on service), and house staff including residents, interns and/or nurse practitioners. The resident will strengthen his/her clinical acumen and communication skills through the completion of one inpatient and two outpatient rotations, including the Phase 1 clinical treatment unit. There are ample opportunities for elective rotations throughout the medical center which can be tailored to the resident’s interests. The program is flexible and can be customized, at the discretion of the Director, to target the resident’s interests and goals. Rotations can be 4 to 8 week long or longitudinal experiences spanning several months.
Research or Quality Project:
All residents will undergo focused training in research through a Resident Research Series. Residents are required to devise, execute and assess a longitudinal project in quality improvement or research as part of the ASHP standards. The resident will be responsible for all aspects of the project including: project development, IRB proposal, data collection and analysis, presentation of the data, and manuscript preparation. Opportunities exist for research presentations at a variety of national & regional conferences including HOPA Annual Meeting and Great Lakes Pharmacy Residency Conference. Research project manuscript will be submitted for publication in a peer-reviewed journal while quality improvement projects may be presented internally.
Medication Use Evaluation:
The resident will be required to complete an MUE during residency. MUE topics commonly involve evaluations of current processes and protocols. Preceptors evaluate the resident’s research and writing skills, and then provide feedback on the MUE in order to further develop and refine the resident’s skills. If applicable, the information will be used to develop or revise an existing guideline to be presented at a designated meeting (i.e., P&T).
The resident will participate in the education of PharmD students enrolled at The Ohio State University and have the opportunity to deliver didactic lectures and precept PharmD students. As the resident progresses through the program, the resident may participate in the education of PGY1 pharmacy residents.
The resident will be assigned to participate in Hem/Onc P&T Committee, Institutional Review Board (either Cancer or Biomedical), and additional committee work as needed.
The staffing commitment is 20 weekends as a licensed pharmacist in the state of Ohio scheduled as (approximately) every other weekend. Residents will be asked to participate in operational staffing. Each year residents are required to work during 1 major holiday and 2 minor holidays.
Applicants must have a PharmD and be eligible for licensure in the state of Ohio.
About The Ohio State University Wexner Medical Center
As one of America’s top ranked academic medical centers, the mission of The Ohio State University Wexner Medical Center (OSUWMC) is to improve people’s lives through innovation in research, education, and patient care.
OSUWMC is a 1443 bed multihospital delivery system recognized in 2018 as one of “America’s Best Hospitals” for excellence in ten specialties by US News and World Report based on quality, outcomes, and reputation. OSUWMC is home to more "Top Doctors" than any other central Ohio hospital.